These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 20500773)
1. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Correll A; Tuettenberg A; Becker C; Jonuleit H Exp Dermatol; 2010 Aug; 19(8):e213-21. PubMed ID: 20500773 [TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination. Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789 [TBL] [Abstract][Full Text] [Related]
3. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2. Bjoern J; Brimnes MK; Andersen MH; Thor Straten P; Svane IM Scand J Immunol; 2011 Mar; 73(3):222-33. PubMed ID: 21204893 [TBL] [Abstract][Full Text] [Related]
4. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
5. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2. Berntsen A; Brimnes MK; thor Straten P; Svane IM J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464 [TBL] [Abstract][Full Text] [Related]
6. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients. Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
10. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. Nicholaou T; Ebert LM; Davis ID; McArthur GA; Jackson H; Dimopoulos N; Tan B; Maraskovsky E; Miloradovic L; Hopkins W; Pan L; Venhaus R; Hoffman EW; Chen W; Cebon J Clin Cancer Res; 2009 Mar; 15(6):2166-73. PubMed ID: 19276262 [TBL] [Abstract][Full Text] [Related]
11. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102 [TBL] [Abstract][Full Text] [Related]
12. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Nair S; Boczkowski D; Fassnacht M; Pisetsky D; Gilboa E Cancer Res; 2007 Jan; 67(1):371-80. PubMed ID: 17210720 [TBL] [Abstract][Full Text] [Related]
13. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
14. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Kaufman HL; Kim DW; DeRaffele G; Mitcham J; Coffin RS; Kim-Schulze S Ann Surg Oncol; 2010 Mar; 17(3):718-30. PubMed ID: 19915919 [TBL] [Abstract][Full Text] [Related]